474 filings
Page 5 of 24
6-K
p9eh 6td1p8m4x5y47g7
11 Dec 23
MorphoSys’ Pelabresib Improves All Four Hallmarks of Myelofibrosis in Phase 3 MANIFEST-2 Study
11:26am
6-K
9n8m2h7jo9h hbcn4q77
7 Dec 23
Current report (foreign)
10:13am
6-K
4nqt0uy o8
6 Dec 23
Current report (foreign)
10:44am
6-K
waq69shv1ubmmn0w
5 Dec 23
Current report (foreign)
10:13am
6-K
fwx6lw4fdr5ewbm 529
4 Dec 23
Current report (foreign)
10:06am
6-K
ie3iji
1 Dec 23
Current report (foreign)
10:23am
6-K
fnpzju 7y52y
30 Nov 23
Current report (foreign)
11:19am
6-K
d2dsp e44kqnm
29 Nov 23
Current report (foreign)
10:26am
6-K
iaks mh6f58
27 Nov 23
Current report (foreign)
10:14am
6-K
8t6dn
24 Nov 23
Current report (foreign)
6:04am
6-K
oxyfkn2
22 Nov 23
Current report (foreign)
10:41am
6-K
trpbch16 u7jfaj
21 Nov 23
Topline Results Phase 3 MANIFEST-2 Study Pelabresib in First-Line Myelofibrosis November 2023 Gail, Living with Myelofibrosis since 2018
10:08am
6-K
l0t0q u8e9
20 Nov 23
Current report (foreign)
4:55pm
6-K
o950n
20 Nov 23
Current report (foreign)
10:06am
6-K
ip5tswot7p00pyv9
16 Nov 23
Current report (foreign)
10:22am
6-K
5bkotn
16 Nov 23
Half-Year Report JANUARY – JUNE
9:25am
6-K
nvz 3oo7k85g
16 Nov 23
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
9:03am
6-K
icnx kxckhievuh
16 Nov 23
Third Quarter Interim Statement JANUARY – SEPTEMBER 2023
6:00am
6-K
vt7e0 024
14 Nov 23
Current report (foreign)
10:28am
6-K
37s3e zzony
13 Nov 23
Current report (foreign)
10:07am